These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2385960)

  • 21. Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.
    Rubio MP; Guerra S; Almendral JM
    J Virol; 2001 Dec; 75(23):11573-82. PubMed ID: 11689639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular transforming genes and oncogenesis.
    Cooper GM; Lane MA
    Biochim Biophys Acta; 1984; 738(1-2):9-20. PubMed ID: 6331501
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells.
    Classon M; Henriksson M; Sümegi J; Klein G; Hammarskjöld ML
    Nature; 1987 Nov 19-25; 330(6145):272-4. PubMed ID: 2823151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The replication of rodent parvovirus X14.
    Mayor HD; Jordan LE
    J Gen Virol; 1976 Mar; 30(3):337-46. PubMed ID: 1255136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines.
    Middleton PG; Miller S; Ross JA; Steel CM; Guy K
    Int J Cancer; 1992 Sep; 52(3):451-4. PubMed ID: 1339415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
    Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
    Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA replication of parvovirus B 19 in a human erythroid leukemia cell line (JK-1) in vitro.
    Takahashi T; Ozawa K; Takahashi K; Okuno Y; Takahashi T; Muto Y; Takaku F; Asano S
    Arch Virol; 1993; 131(1-2):201-8. PubMed ID: 8328914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of EBV in Burkitt's lymphoma cells.
    Delecluse HJ; Kohls S; Bullerdiek J; Bornkamm GW
    Curr Top Microbiol Immunol; 1992; 182():367-73. PubMed ID: 1337031
    [No Abstract]   [Full Text] [Related]  

  • 31. Epstein-Barr virus: structure of the viral DNA and analysis of viral RNA in infected cells.
    Kieff E; Given D; Powell AL; King W; Dambaugh T; Raab-Traub N
    Biochim Biophys Acta; 1979 Nov; 560(3):355-73. PubMed ID: 228726
    [No Abstract]   [Full Text] [Related]  

  • 32. Superinfection with adenovirus of lymphoblastoid cell lines.
    Chardonnet Y; Perrinet MC; Faucon N
    IARC Sci Publ (1971); 1975; (11 Pt 1):497-500. PubMed ID: 190157
    [No Abstract]   [Full Text] [Related]  

  • 33. Size heterogeneity of EBV and mitochondrial DNAs in Burkitt's lymphoma lines.
    Kinchington D; Griffin BE
    Nucleic Acids Res; 1987 Dec; 15(24):10345-54. PubMed ID: 2827120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic.
    Chen YQ; Tuynder MC; Cornelis JJ; Boukamp P; Fusenig NE; Rommelaere J
    Carcinogenesis; 1989 Jan; 10(1):163-7. PubMed ID: 2463114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent association of protein with replicative form DNA of parvovirus H-1.
    Revie D; Tseng BY; Grafstrom RH; Goulian M
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5539-43. PubMed ID: 293659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bovine parvovirus replication on DNA, RNA, and protein synthesis in S phase cells.
    Parris DS; Bates RC
    Virology; 1976 Aug; 73(1):72-8. PubMed ID: 986723
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of RAS oncogene mutations in human lymphoid malignancies.
    Neri A; Knowles DM; Greco A; McCormick F; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9268-72. PubMed ID: 3057505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of multiple forms of the noncapsid parvovirus protein NCVP1 in H-1 parvovirus-infected cells.
    Paradiso PR
    J Virol; 1984 Oct; 52(1):82-7. PubMed ID: 6481857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.